KRAS and neoplasm: Some specific RAS mutations show high prevalence in particular tumor types, with the KRAS G12D mutation found in 44% of colorectal cancers and 39% of pancreatic cancers, while 59% of non-small cell lung cancers harbor KRAS G12C mutations [8].